Natalie Holles
2016 - Audentes Therapeutics
In 2016, Natalie Holles earned a total compensation of $463.2K as Senior Vice President, Chief Operating Officer at Audentes Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $102,743 |
|---|---|
| Salary | $360,500 |
| Total | $463,243 |
Holles received $360.5K in salary, accounting for 78% of the total pay in 2016.
Holles also received $102.7K in non-equity incentive plan.
Rankings
In 2016, Natalie Holles' compensation ranked 11,441st out of 14,075 executives tracked by ExecPay. In other words, Holles earned more than 18.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,441 out of 14,075 | 19th |
Division Manufacturing | 4,458 out of 5,489 | 19th |
Major group Chemicals And Allied Products | 1,599 out of 1,895 | 16th |
Industry group Drugs | 1,294 out of 1,538 | 16th |
Industry Biological Products, Except Diagnostic Substances | 230 out of 279 | 18th |
Source: SEC filing on April 27, 2017.
Holles' colleagues
We found three more compensation records of executives who worked with Natalie Holles at Audentes Therapeutics in 2016.